Director Peter Barrett to resign from Larimar Therapeutics Board effective May 9, 2023

Larimar Therapeutics, Inc.

Peter Barrett, Ph.D., resigned from the Board, effective May 9, 2023, the date of the 2023 Annual Meeting.
Dr. Barrett's resignation did not result from any disagreement with the Company on operations, policies, or practices.
The Company expressed gratitude for Dr. Barrett's distinguished service and lasting contributions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Peter Barrett

Director

LRMR · Larimar Therapeutics, Inc.

Effective: 2023-05-09
Filed: April 6, 2023, 7:59 PM ET

On April 3, 2023, Peter Barrett, Ph.D., a member of the Board of Directors (the “ Board ”) of Larimar Therapeutics, Inc. (the “ Company ”), tendered his resignation from the Board to be effective as of May 9, 2023, the date of the Company’s 2023 Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Peter Barrett resigned as Director at Larimar Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On April 3, 2023, Peter Barrett, Ph.D., a member of the Board of Directors (the “ Board ”) of Larimar Therapeutics, Inc. (the “ Company ”), tendered his resignation from the Board to be effective as of May 9, 2023, the date of the Company’s 2023 Annual Meeting of Stockholders.

View on SEC.gov

Larimar Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-093965

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.